Chelsea Therapeutics confirms FDA approval of Northera, halt lifted at 5:25

|About: Chelsea Therapeutics Intern... (CHTP)|By:, SA News Editor

The FDA confirms it approved Chelsea Therapeutics' (CHTP) Northera capsules for the treatment of neurogenic orthostatic hypotension.

Northera will contain a boxed warning to alert doctors and patients about applicable risks, and the package insert indicates that effectiveness beyond two weeks of treatment has not yet been demonstrated, but there's no restriction on prescription use.

CHTP calls the approval "an extraordinary achievement."

Shares to resume trading at 5:25.